Chuck Aldridge, OD, MBA, FAAO

Dr. Aldridge is a graduate of Southern College of Optometry and practices in Burnsville, NC. He lectures and writes on ocular disease, contact lenses, and practice management. He is a consultant to TearLab, Alcon, and Allergan.


Rethinking once-daily dosing on allergy medications

Ideally, an ocular allergy medication should provide clinically significant improvements of the annoying or even incapacitating ocular itch with minimal dosing. While this is a desirable goal, it leads to challenges of the amount of dosing to achieve this objective and patient compliance with such dosing.